BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11257761)

  • 1. [Evaluation of time dependency of the acetazolamide effect on cerebral hemodynamics as measured by 99mTc-ECD single-photon emission computed tomography].
    Takaki A; Mizuta Y; Murakami M; Yonehara T; Urata J; Okada K; Takaki R; Hirano T; Fujioka S
    Kaku Igaku; 2001 Jan; 38(1):31-8. PubMed ID: 11257761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of delayed appearance of acetazolamide effect in patients with chronic cerebrovascular ischemic disease: feasibility and usefulness of SPECT method using triple injection of ECD.
    Murakami M; Yonehara T; Takaki A; Fujioka S; Hirano T; Ushio Y
    J Nucl Med; 2002 May; 43(5):577-83. PubMed ID: 11994517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L,L-ECD SPECT activated with acetazolamide: quantification analysis by equal-volume-split 99mTc-ECD consecutive SPECT method.
    Takeuchi R; Matsuda H; Yonekura Y; Sakahara H; Konishi J
    J Cereb Blood Flow Metab; 1997 Oct; 17(10):1020-32. PubMed ID: 9346426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of cerebral blood flow with 99mTc-ECD SPECT and its potential clinical implications--analyzing the relationships between CBF and lifestyle disease].
    Nemoto H; Nakai Y; Hatakeyama R; Shikano N; Jesmin S; Yamaguchi N
    Kaku Igaku; 2012 Nov; 49(4):329-40. PubMed ID: 23402203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-day protocol for cerebral perfusion reserve with acetazolamide.
    Hattori N; Yonekura Y; Tanaka F; Fujita T; Wang J; Ishizu K; Okazawa H; Tamaki N; Konishi J
    J Nucl Med; 1996 Dec; 37(12):2057-61. PubMed ID: 8970534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L, L-ECD SPECT activated with acetazolamide].
    Takeuchi R; Matsuda H; Sakahara H; Konishi J
    Kaku Igaku; 1996 Nov; 33(11):1213-20. PubMed ID: 8986060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting and acetazolamide-challenged technetium-99m-ECD SPECT in transient global amnesia.
    Takeuchi R; Yonekura Y; Matsuda H; Nishimura Y; Tanaka H; Ohta H; Sakahara H; Konishi J
    J Nucl Med; 1998 Aug; 39(8):1360-2. PubMed ID: 9708507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cerebral blood flow reserve in patients with cerebrovascular disease by SPECT using technetium-99m-L, L-ethyl cysteinate dimer.
    Hori A; Harada M; Nishitani H; Uno M
    J Med Invest; 2002 Aug; 49(3-4):134-41. PubMed ID: 12323002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.
    Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA
    J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease.
    Ohnishi T; Yano T; Nakano S; Jinnouchi S; Nagamachi S; Flores LI; Nakahara H; Watanabe K
    J Nucl Med; 1997 Sep; 38(9):1463-7. PubMed ID: 9293809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and assessment of an automatic quantitative cerebral vascular reserve estimation tool for use with triple-injection 99mTc-ECD SPECT].
    Takaki A; Yoshioka K; Teraoka S; Souma T; Kawakami K; Yokoi T; Murase K
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2007 May; 63(5):563-9. PubMed ID: 17538222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion MRI before and after acetazolamide administration for assessment of cerebrovascular reserve capacity in patients with symptomatic internal carotid artery (ICA) occlusion: comparison with 99mTc-ECD SPECT.
    Ma J; Mehrkens JH; Holtmannspoetter M; Linke R; Schmid-Elsaesser R; Steiger HJ; Brueckmann H; Bruening R
    Neuroradiology; 2007 Apr; 49(4):317-26. PubMed ID: 17200864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of signal-to-noise ratio using iterative reconstruction in a 99m Tc-ECD split-dose injection protocol.
    Yokoi T; Shinohara H; Takaki A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1125-33. PubMed ID: 12768331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Fukumura T; Masuda K; Fujii K; Fukui M
    J Nucl Med; 1998 May; 39(5):760-5. PubMed ID: 9591570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m-ECD brain SPECT in misery perfusion.
    Shimosegawa E; Hatazawa J; Aizawa Y; Shouji Y; Hachiya T; Murakami M
    J Nucl Med; 1997 May; 38(5):791-6. PubMed ID: 9170448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
    Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
    World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO].
    Makino K; Masuda Y; Gotoh S
    Kaku Igaku; 1996 May; 33(5):551-5. PubMed ID: 8699624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardised 99mTc-ECD SPET.
    Takeuchi R; Yonekura Y; Matsuda H; Konishi J
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):331-41. PubMed ID: 12002707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of brain SPECT to evaluate brain tolerance and hemodynamic changes during temporary balloon occlusion test and after permanent carotid occlusion.
    Sugawara Y; Kikuchi T; Ueda T; Nishizaki M; Nakata S; Mochizuki T; Ikezoe J
    J Nucl Med; 2002 Dec; 43(12):1616-23. PubMed ID: 12468510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.